SCHEMBL10153281

SCHEMBL10153281

COC(=O)c1cc(NC(=O)c2ccccc2)ccc1C(C(=O)OC)C(=O)OC

nearest known ligand 0.59

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 7/20 0.59
KDM4E B2RXH2 3/20 0.59
MAPT P10636 3/20 0.59
MEN1 O00255 3/20 0.59
KMT2A Q03164 3/20 0.59
LMNA P02545 2/20 0.59
RAB9A P51151 8/20 0.57
PTPN1 P18031 1/20 0.52
NPC1 O15118 7/20 0.50
HTT P42858 3/20 0.50
MAPK1 P28482 1/20 0.49
HSD17B10 Q99714 1/20 0.49
NLRP3 Q96P20 1/20 0.49
ALDH1A1 P00352 1/20 0.49
KCNK9 Q9NPC2 4/20 0.48
KCNK3 O14649 3/20 0.48
GAA P10253 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10153984 0.85 SMN1; SMN2 (0.47) SMN1; SMN2KDM4EMAPTMEN1KMT2A
SCHEMBL10153683 0.83 SMN1; SMN2 (0.56) SMN1; SMN2KDM4EMAPTRAB9ANPC1
SCHEMBL9961071 0.82 SMN1; SMN2 (0.57) SMN1; SMN2KDM4EMAPTMEN1KMT2A
SCHEMBL28438951 0.82 RAB9A (0.68) SMN1; SMN2KDM4EMAPTMEN1KMT2A
SCHEMBL10153648 0.81 ALDH1A1 (0.59) SMN1; SMN2KDM4EMAPTMEN1KMT2A
SCHEMBL6859800 0.80 MAPT (0.64) SMN1; SMN2KDM4EMAPTMEN1KMT2A
SCHEMBL20522767 0.79 RAB9A (0.66) SMN1; SMN2KDM4EMAPTMEN1KMT2A
SCHEMBL7050973 0.79 KCNK9 (0.67) SMN1; SMN2KDM4EMAPTMEN1KMT2A
SCHEMBL4241238 0.76 KMT2A (0.68) SMN1; SMN2KDM4EMAPTMEN1KMT2A
SCHEMBL11170486 0.76 RAB9A (0.62) SMN1; SMN2KDM4EMAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012085003-A1 2-HYDROXYISOQUINOLINE-1,3(2H,4H)-DIONES AND RELATED COMPOUNDS USEFUL AS HIV REPLICATION INHIBITORS KATHOLIEKE UNIVERSITEIT LEUVEN, K.U. LEUVEN R&D (BE) 2012-06-28 WO disclosed